is there a link between glp-1 drugs and blood clots medicines may cut clot-related risks in chronically inflamed patients January 2025: GLP Drugs -

250 mg ** trans-Resveratrol (as Polygonum cuspidatum root extract)

Moreover, we excluded patients and controls who suffered from neurodegenerative and neuroinflammatory disorders, such as chronic fatigue syndrome [54], Parkinsons or Alzheimers disease, multiple sclerosis, stroke, or systemic (auto)immune diseases such as diabetes mellitus, psoriasis, rheumatoid arthritis, inflammatory bowel disease and scleroderma, and liver and renal disease

PubMed , doi:10.1123/ijsnem.2018-0339

The intent is synergy: one peptide supports repair signaling, another supports tissue organization, and another supports structural rebuilding

Tangerine Peel Extract

doi: 10.3390/molecules27175730 3 HamdyFCDonovanJLLaneJAMasonMMetcalfeCHoldingPet al